Meeting
2024 ASCO Annual Meeting
Alliance A022106: A phase II/III trial of NABPLAGEM vs nab-paclitaxel/gemcitabine as second-line treatment for BRCA1/2 or PALB2 mutant metastatic pancreatic ductal adenocarcinoma (PLATINUM).
Authors
Erica S Tsang
Princess Margaret Cancer Centre, Toronto, ON, Canada
Erica S Tsang , Qian Shi , Kenneth P. Olive , Eric Andrew Collisson , Jesse G. Dixon , Mike Cusnir , Rafael Winograd , Gregory P. Botta , Raymond Couric Wadlow , Ardaman Shergill , Jeffrey A. Meyerhardt , Eileen M. O'Reilly , Andrew H. Ko
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Gastrointestinal Cancer—Gastroesophageal, Pancreatic, and Hepatobiliary
Track
Gastrointestinal Cancer—Gastroesophageal, Pancreatic, and Hepatobiliary
Sub Track
Pancreatic Cancer - Advanced/Metastatic Disease
Clinical Trial Registration Number
NCT06115499
Citation
J Clin Oncol 42, 2024 (suppl 16; abstr TPS4205)
DOI
10.1200/JCO.2024.42.16_suppl.TPS4205
Abstract #
TPS4205
Poster Bd #
172b
Abstract Disclosures
Similar Posters
Poster
2023 ASCO Annual Meeting
Randomized phase II trial of olaparib + pembrolizumab vs olaparib alone as maintenance therapy in metastatic pancreatic cancer patients with germline BRCA1 or BRCA2 (gBRCA1/2+) pathogenic variants: SWOG S2001.
First Author: Vincent Chung
Poster
2023 ASCO Gastrointestinal Cancers Symposium
Metronomic oral cyclophosphamide as maintenance therapy in metastatic pancreatic ductal adenocarcinoma.
First Author: Michele Reni
Poster
2021 Gastrointestinal Cancers Symposium
Real-world study of treatment patterns and outcomes among patients with metastatic pancreatic ductal adenocarcinoma (PDAC) in Europe.
First Author: Julien Taieb
Poster
2020 Gastrointestinal Cancers Symposium
Homologous recombination deficiency (HRD) scoring in pancreatic ductal adenocarcinoma (PDAC) and response to chemotherapy.
First Author: Grainne M. O'Kane